Our data in colon cancer showed that the majority of mutations identified were shared between a primary tumor and its cognate paired metastatic lesion, including KRAS, APC, and PIK3CA which are commonly tested mutations in our patients. This evidence concerns the gene APC and colonic neoplasm.